logo
episode-header-image
Aug 2024
28m 8s

AI-Powered Weapons Startup Raises $1.5B ...

Morning Brew
About this episode
Episode 384: Neal and Toby chat about the round of funding for a startup that could transform the landscape of warfare by combining tech and military manufacturing. Then, upheaval in Bangladesh has global economies nervous about its impacts, especially in the fashion industry. Next, Warner Bros. Discovery and Paramount both had massive write-downs which furt ... Show More
Up next
Yesterday
Trump Strikes Controversial Oil Deal With Russia & Low Payroll MLB Teams Dominate Postseason
#953: Trump faces backlash after securing a deal with Russia for diesel fuel. Pepsi is feeling the hurt as the GLP-1 movement is causing shoppers to cut back on sodas and snacks. Two American economists win the Nobel Prize for their work on managing economic shocks. 3 out of the ... Show More
32m 9s
Oct 12
Bond Yields Are Rising. A Bond Nerd Explains Why It Matters
#952: Robin Wigglesworth is the editor of the Financial Times’ Alphaville blog and the author of A Fabulous Debt: The Epic Story of How Bonds Built the Modern World. He joins Toby to explain the history behind the bond market, some of the major players that modernized bonds, and ... Show More
34m 56s
Oct 9
Could a Chipotle-Starbucks Merger Actually Work? & Hollywood Turns on Big Tech
#951: Rumblings of Starbucks’ takeover of Chipotle sends the burrito chain’s shares up. Aaron Sorkin’s ‘The Social Reckoning’ hits theaters, headlining Hollywood’s new crusade of showing the ugly side of Big Tech. Duke math majors can earn up to $300,000 as soon they graduate!? S ... Show More
29m 39s
Recommended Episodes
Dec 2023
Pfizer’s Second Gut Punch Shows Pitfalls of Weight-Loss Pills
 Bloomberg News Health Reporter Madison Muller explains how Pfizer’s second weight-loss setback this year is a warning sign that breaking into the lucrative obesity market isn’t going to be easy. Cory Klippsten, CEO at Swan Bitcoin, shares his crypto outlook for 2024. Benjamin Wo ... Show More
42m 33s
Nov 2023
Obesity Drugs Enjoy a Much-Needed Winning Streak
Bloomberg Opinion Pharma Columnist Lisa Jarvis and Bloomberg News Health Reporter Madison Muller discuss a how a clinical trial in obesity drugs is punctuating a string of positive developments that could make the treatments more widely accessible. Kate Hao, Founder and CEO of Ha ... Show More
41m 10s
Oct 2023
Congress in Chaos, The Ozempic Effect, and the Healthcare Strike
Kara and Scott discuss declining social media traffic to news sites, Amazon using an algorithm to test how high they could boost prices, and why the boom in weight loss drugs is the “biggest business story of the year.” Also, Kevin McCarthy’s historic ouster marks another predict ... Show More
1h 4m
Nov 2025
Pfizer plays hardball in weight-loss drug fight
Palantir lifted its 2025 revenue guidance and Pfizer has filed a second lawsuit against Novo Nordisk and obesity drug start-up Metsera. Plus, OpenAI inked a $38bn computing deal with Amazon, and the FT’s Claire Jones explains how the Trump administration is considering pushing fo ... Show More
11m 3s
Apr 2025
20VC: The Daily Deal: Coreweave IPO | Scale Hits $25BN on $2BN EOY Revenue | Sequoia's 25x Return on Wiz | Tech Stocks Tank with Tariffs | Cursor: Defensible or Dangerous Example of Lost Moats in Tech
<p><span class="yt-core-attributed-string--link-inherit-color" dir= "auto">Welcome to The Daily Deal — the new show with Harry Stebbings and Jason Lemkin, where we break down the biggest stories in tech, venture, and B2B. From market meltdowns to billion-dollar raises, wild valua ... Show More
1h 27m
Mar 2025
Trump-Carney call, Dow plunges, cloning fashion models & more
We start with an escalating trade war between the US and Canada. Hot inflation data has investors worried. Search and rescue operations are underway following a devastating earthquake in Myanmar. Tensions are ramping up again between Israel and Hezbollah. Plus, we’ll tell you how ... Show More
6m 49s
May 2025
Bond crisis looming? GOP abandons DOGE, Google disrupts Search with AI, OpenAI buys Jony Ive's IO
(0:00) Today's topics and bestie intros! (2:49) Bond market chaos, GOP abandons DOGE, Trump's big, beautiful bill passes the House (38:15) Google's big week: AI in search, roadmap to diversifying revenue (46:49) OpenAI acquires Jony Ive's design startup for $6.5B (57:09) AI Diplo ... Show More
1h 33m
Aug 2024
👁️ “Nvidia’s watch party” — A.I.'s Biggest Day. Mister Softee’s soft-serve biz. Ozempic’s Direct-To-Tummy.
Nvidia just announced earnings that were so big, people hosted parties… but the results were a Rorschach Test for Wall Street.Mister Softee’s ice cream trucks have shrank in number by two thirds… because of competition, climate change, and street corners.Ozempic has a new strateg ... Show More
23m 43s
Jun 2024
Apple’s Record High… And Structure Therapeutics’ CEO On Weight Loss Drugs 6/11/24
<p>Shares of Apple jumping to record highs just a day after falling flat on its new AI announcements. The turnaround for the tech titan, and what it means for the market. Plus The weight loss wars rage on… and we’re honing in on oral version of GLP-1’s. How one pharma stock is fa ... Show More
43m 43s